Idiopathic Pulmonary Fibrosis

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
Makon-Sébastien Njock, Julien Guiot, Monique A Henket, Olivier Nivelles, Marc Thiry, Franck Dequiedt, Jean-Louis Corhay, Renaud E Louis, Ingrid Struman

Thorax Mar 2019, 74 (3) 309-312; DOI: 10.1136/thoraxjnl-2018-211897
Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis
Gary M Hunninghake

Thorax Feb 2019, thoraxjnl-2018-212446; DOI: 10.1136/thoraxjnl-2018-212446
Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis
John E McDonough, Naftali Kaminski, Bernard Thienpont, James C Hogg, Bart M Vanaudenaerde, Wim A Wuyts

Thorax Feb 2019, 74 (2) 132-140; DOI: 10.1136/thoraxjnl-2018-211929
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
Prosenjit Dutta, Wendy Funston, Helen Mossop, Vicky Ryan, Rhys Jones, Rebecca Forbes, Shilpi Sen, Jeffrey Pearson, S Michael Griffin, Jaclyn A Smith, Christopher Ward, Ian A Forrest, A John Simpson

Thorax Jan 2019, thoraxjnl-2018-212102; DOI: 10.1136/thoraxjnl-2018-212102
Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF
Nicholas D Weatherley, Neil J Stewart, Ho-Fung Chan, Matthew Austin, Laurie J Smith, Guilhem Collier, Madhwesha Rao, Helen Marshall, Graham Norquay, Stephen A Renshaw, Stephen Mark Bianchi, Jim M Wild

Thorax Nov 2018, thoraxjnl-2018-211851; DOI: 10.1136/thoraxjnl-2018-211851
Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers
Samuel Y Ash, Rola Harmouche, Rachel K Putman, James C Ross, Fernando J Martinez, Augustine M Choi, Russell P Bowler, Elizabeth A Regan, Jeffrey L Curtis, MeiLan K Han, Richard C Boucher, Wanda K O’Neal, Hiroto Hatabu, David A Lynch, Ivan O Rosas, Gary M Hunninghake, Raul San Jose Estepar, George R Washko

Thorax Nov 2018, 73 (11) 1071-1074; DOI: 10.1136/thoraxjnl-2017-211208
Interstitial lung abnormalities and self-reported health and functional status
Gisli Thor Axelsson, Rachel K Putman, Tetsuro Araki, Sigurdur Sigurdsson, Elias Freyr Gudmundsson, Gudny Eiriksdottir, Thor Aspelund, Ezra R Miller, Lenore J Launer, Tamara B Harris, Hiroto Hatabu, Vilmundur Gudnason, Gary Matt Hunninghake, Gunnar Gudmundsson

Thorax Sep 2018, 73 (9) 884-886; DOI: 10.1136/thoraxjnl-2017-210956
Timing of onset of symptoms in people with idiopathic pulmonary fibrosis
Thomas Hewson, Tricia M McKeever, Jack E Gibson, Vidya Navaratnam, Richard B Hubbard, John P Hutchinson

Thorax Jul 2018, 73 (7) 683-685; DOI: 10.1136/thoraxjnl-2017-210177
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
Luca Richeldi, Michael Kreuter, Moisés Selman, Bruno Crestani, Anne-Marie Kirsten, Wim A Wuyts, Zuojun Xu, Katell Bernois, Susanne Stowasser, Manuel Quaresma, Ulrich Costabel

Thorax Jun 2018, 73 (6) 581-583; DOI: 10.1136/thoraxjnl-2016-209701
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
Javier Milara, Beatriz Ballester, Anselm Morell, José L Ortiz, Juan Escrivá, Estrella Fernández, Francisco Perez-Vizcaino, Angel Cogolludo, Enrique Pastor, Enrique Artigues, Esteban Morcillo, Julio Cortijo

Thorax Jun 2018, 73 (6) 519-529; DOI: 10.1136/thoraxjnl-2017-210728

Main menu

Idiopathic Pulmonary Fibrosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Idiopathic Pulmonary Fibrosis

Pages